Patent · US Active

CDK2/4/6 inhibitors

US11396512B2 · kind B2 · utility

0Cited by
0References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 27, 2020
Grant dateJul 26, 2022
Priority date
Expiry dateAug 27, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D471/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

This invention relates to compounds of general Formula (I)

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.